GTBPVSHALO• 6 Months (Normalized)
GTBP vs HALO (GT Biopharma Inc. vs Halozyme Therapeutics Inc.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+1406.17%
GT Biopharma Inc.
Normalized Baseline0.00%
HALO Performance $109.86
+67.9%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1338.27 pts
GTBP outperforming by 1338.27 percentage points
GTBPHALO
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP HALO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | GTBP Price | GTBP Gain (%) | HALO Price | HALO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +1406.17% | $109.86 | +67.90% | +1338.27% |
| Oct 01, 2026 | $- | $106.94 | +63.44% | - | |
| Sep 30, 2026 | $- | $110.40 | +68.73% | - | |
| Sep 29, 2026 | $6.88 | +1597.53% | $111.56 | +70.50% | +1527.03% |
| Sep 28, 2026 | $6.80 | +1579.01% | $112.89 | +72.54% | +1506.47% |
| Sep 25, 2026 | $6.89 | +1601.23% | $113.90 | +74.08% | +1527.15% |
| Sep 24, 2026 | $6.83 | +1586.42% | $- | - | |
| Sep 23, 2026 | $7.10 | +1653.09% | $112.44 | +71.85% | +1581.24% |
| Sep 22, 2026 | $- | $115.13 | +75.96% | - | |
| Sep 21, 2026 | $7.18 | +1672.84% | $111.45 | +70.33% | +1602.51% |
| Sep 18, 2026 | $7.16 | +1667.90% | $112.45 | +71.86% | +1596.04% |
| Sep 17, 2026 | $7.49 | +1749.38% | $109.68 | +67.63% | +1681.75% |
| Sep 16, 2026 | $7.81 | +1828.40% | $108.44 | +65.73% | +1762.67% |
| Sep 15, 2026 | $9.00 | +2122.22% | $106.25 | +62.39% | +2059.83% |
| Sep 14, 2026 | $11.63 | +2771.60% | $107.94 | +64.97% | +2706.63% |
Page 1 of 9